1.Diabetic Neuropathic Cachexia in a Young Woman
Nurul Azreen YUSOF ; Nur Suhaila IDRIS ; Faridah Mohd ZIN
Korean Journal of Family Medicine 2019;40(3):194-198
Profound weight loss with painful symmetrical peripheral neuropathy in diabetic patients was first described as diabetic neuropathic cachexia more than 4 decades ago. It is a distinct type of diabetic peripheral neuropathy that occurs in the absence of other microvascular and autonomic complications of diabetes. The mechanism and precipitating cause are unknown. It was reported to have good prognosis with spontaneous recovery within months to 2 years. However, it was frequently missed by clinicians because the profound weight loss is the most outstanding complaint, rather than the pain, numbness, or weakness. This often leads to extensive investigation to exclude more sinister causes of weight loss, particularly malignancy. We report a case of a young woman with well-controlled diabetes who presented with profound unintentional weight loss (26 kg), symmetrical debilitating thigh pain, and clinical signs of peripheral neuropathy. As the disease entity may mimic an inflammatory demyelinating cause of neuropathy, she was treated with a trial of intravenous immunoglobulin, which failed to give any significant benefit. However, she recovered after 6 months without any specific treatment, other than an antidepressant for the neuropathic pain and ongoing rehabilitation.
Cachexia
;
Diabetic Neuropathies
;
Female
;
Humans
;
Hypesthesia
;
Immunoglobulins
;
Neuralgia
;
Peripheral Nervous System Diseases
;
Prognosis
;
Rehabilitation
;
Thigh
;
Weight Loss
2.Alternative Tobacco Products Use among Late Adolescents in Kelantan, Malaysia
Nurul Azreen YUSOF ; Faridah Mohd ZIN ; Nur Suhaila IDRIS ; Rosediani MOHAMMAD
Korean Journal of Family Medicine 2019;40(4):254-260
BACKGROUND: The rising prevalence of alternative tobacco and nicotine products (ATNPs) use among adolescents is a global concern that has been attributed to the reemergence of preexisting alternative tobacco products and emergence of new ones in the market. This study examined ATNP use among late adolescents. The association between ATNP use and reasons for using them was explored. METHODS: This cross-sectional study conducted in 2016 involving 388 late adolescents from six government colleges in Kelantan, Malaysia, aged 18 to 19 years. They were requested to answer self-directed questionnaires with items on sociodemographic information and types of ATNP used. Other variables obtained include the environmental influence and reasons for using the products. Regression analyses between the dependent and independent variables were conducted using IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA). RESULTS: The prevalence of ATNP use among late adolescents was 14.4%. The male sex, cigarette smoking status, and peer use were significantly associated with ATNP use. Several reasons for use were not significantly associated with ATNP use: perception of ATNP being less harmful and less addictive compared with cigarettes, curiosity, less expensive than cigarettes, to aid smoking cessation, and pleasurable flavors and taste. CONCLUSION: The prevalence of ATNP use among late adolescents studying in government colleges in Kelantan is significant. There is higher perception on ATNP being less harmful and addictive than the conventional cigarette among the users compared with non-users. Significant associations are seen for the male sex, peer use, and concurrent cigarette smoking.
Adolescent
;
Cross-Sectional Studies
;
Exploratory Behavior
;
Humans
;
Malaysia
;
Male
;
Nicotine
;
Prevalence
;
Smoking
;
Smoking Cessation
;
Tobacco Products
;
Tobacco
3.Type 2 diabetes remission: How does it work?
Faridah binti Mohd Zin ; Mohd Shahriman bin Ahmad Fuat ; Zainab binti Mat Yudin
Malaysian Family Physician 2021;16(1):124-128
Type 2 diabetes mellitus (Type 2 DM) is a chronic disease which rise is closely linked to the obesity
epidemic and which requires long-term medical attention to limit the development of its wideranged complications. Many of these complications arise from the combination of resistance to
insulin action, inadequate insulin secretion, and excessive or inappropriate glucagon secretion. The
increasing evidence of its remission state has been discussed in the literature. Here we report on a
patient with metabolic syndrome who underwent a structured therapeutic lifestyle changes (TLC)
therapy which eventually led to remission of Type 2 DM.